1-4 of 4
Chiara Cerrato, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

Francesca Gay, MD, Chiara Cerrato, MD, Delia Rota Scalabrini, MD, Monica Galli, MD, Angelo Belotti, MD, Elena Zamagni, MD, Antonio Ledda, MD, Mariella Grasso, MD, Emanuele Angelucci, MD, Anna Marina Liberati, MD, Patrizia Tosi, MD, Francesco Pisani, MD, Stefano Spada, Ombretta Annibali, MD, Anna Baraldi, MD, Paola Omedé, Piero Galieni, MD, Rita Rizzi, MD, Norbert Pescosta, MD, Sonia Ronconi, MD, Donatella Vincelli, MD, Anna Maria Cafro, MD, Massimo Offidani, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 121.
https://doi.org/10.1182/blood-2018-99-112093
Published: 2018
Journal Articles

Impact of Autologous Transplantation Vs. Chemotherapy Plus Lenalidomide in Newly Diagnosed Myeloma According to Patient Prognosis: Results of a Pooled Analysis of 2 Phase III Trials

Francesca Gay, MD, Chiara Cerrato, MD, Roman Hajek, Francesco Di Raimondo, MD, Tommaso Caravita, MD, Antonietta Pia Falcone, MD, Francesca Patriarca, MD, Stefano Pulini, Paola Finsinger, MD, Giovannino Ciccone, Paolo Corradini, MD, Agostina Siniscalchi, MD, Francesca Donato, Dina Ben Yehuda, Massimo Offidani, MD, Jiri Minarik, MD PhD, Roberto Ria, MD, Federica Cavallo, MD, Lucio Catalano, MD, Maide Cavalli, MD, Ludek Pour, Doc, MD PhD, Maria Teresa Petrucci, MD, Izhar Hardan, MD, Mario Boccadoro, MD, Andrew Spencer, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 198.
https://doi.org/10.1182/blood.V124.21.198.198
Published: 2014
Journal Articles

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

Sara Bringhen, MD, Chiara Cerrato, MD, Maria Teresa Petrucci, MD, Mariella Genuardi, MD, Fabiana Gentilini, MD, Concetta Conticello, Stefania Oliva, Lucia Pantani, MD, Massimo Offidani, MD, Carmela Palladino, Giulia Benevolo, MD, Vittorio Montefusco, MD, Monica Astolfi, Oreste Villani, Agostina Siniscalchi, MD, Alberto Rocci, Lorenzo De Paoli, Mario Boccadoro, MD, Pieter Sonneveld, MD, PhD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 685.
https://doi.org/10.1182/blood.V122.21.685.685
Published: 2013
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients

Antonio Palumbo, MD, Sara Bringhen, Oreste Villani, Agostina Siniscalchi, MD, Eleonora Russo, MD, PhD, Giuseppina Uccello, MD, Chiara Cerrato, MD, Milena Gilestro, Davide Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 730.
https://doi.org/10.1182/blood.V120.21.730.730
Published: 2012